Advertisement
Screener

OrthoPediatrics Corp (KIDS) Stock-Based Compensation

2.8 / 5 stars · 68/120 Roast Me

OrthoPediatrics Corp Stock-Based Compensation

OrthoPediatrics Corp (KIDS) reported Stock-Based Compensation of $8.17 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.

Financial Statements › Cash Flow › Operating Activities

us-gaap:ShareBasedCompensation · last filed 2026-08-05

  • OrthoPediatrics Corp share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $4.19M, a 20.20% decline year-over-year.
  • OrthoPediatrics Corp share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $3.98M, a 3.19% increase year-over-year.
  • OrthoPediatrics Corp share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $4.42M, a 13.58% increase year-over-year.
  • OrthoPediatrics Corp share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $4.25M, a 8.39% increase year-over-year.
  • OrthoPediatrics Corp share-based payment arrangement, noncash expense for fiscal 2025 was $17.78M, a 31.22% increase from fiscal 2024.
  • OrthoPediatrics Corp share-based payment arrangement, noncash expense for fiscal 2024 was $13.55M, a 28.71% increase from fiscal 2023.
  • OrthoPediatrics Corp share-based payment arrangement, noncash expense for fiscal 2023 was $10.53M, a 57.60% increase from fiscal 2022.
  • OrthoPediatrics Corp share-based payment arrangement, noncash expense for fiscal 2022 was $6.68M, a 14.33% increase from fiscal 2021.
Period endShare-based Payment Arrangement, Noncash Expense 3 monthShare-based Payment Arrangement, Noncash Expense 6 monthShare-based Payment Arrangement, Noncash Expense 9 monthShare-based Payment Arrangement, Noncash Expense 12 month
2026-06-30$4.19M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
$8.17M
10-Q · filed 2026-08-05
$12.59M
derived: sum of 3 quarters · filed 2026-08-05
$16.84M
derived: sum of 4 quarters · filed 2026-08-05
2026-03-31$3.98M
10-Q · filed 2026-05-01
$8.40M
derived: sum of 2 quarters · filed 2026-05-01
$12.65M
derived: sum of 3 quarters · filed 2026-05-01
$17.90M
derived: sum of 4 quarters · filed 2026-08-05
2025-12-31$4.42M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04
$8.67M
derived: sum of 2 quarters · filed 2026-03-04
$13.92M
derived: sum of 3 quarters · filed 2026-08-05
$17.78M
10-K · filed 2026-03-04
2025-09-30$4.25M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29
$9.50M
derived: sum of 2 quarters · filed 2026-08-05
$13.36M
10-Q · filed 2025-10-29
$17.25M
derived: sum of 4 quarters · filed 2026-08-05
2025-06-30$5.25M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
$9.11M
10-Q · filed 2026-08-05
$13.00M
derived: sum of 3 quarters · filed 2026-08-05
$16.92M
derived: sum of 4 quarters · filed 2026-08-05
2025-03-31$3.86M
10-Q · filed 2026-05-01
$7.75M
derived: sum of 2 quarters · filed 2026-05-01
$11.67M
derived: sum of 3 quarters · filed 2026-05-01
$14.61M
derived: sum of 4 quarters · filed 2026-05-01
2024-12-31$3.89M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04
$7.81M
derived: sum of 2 quarters · filed 2026-03-04
$10.75M
derived: sum of 3 quarters · filed 2026-03-04
$13.55M
10-K · filed 2026-03-04
2024-09-30$3.92M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29
$6.86M
derived: sum of 2 quarters · filed 2025-10-29
$9.66M
10-Q · filed 2025-10-29
$12.41M
derived: sum of 4 quarters · filed 2026-03-04
2024-06-30$2.94M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06
$5.74M
10-Q · filed 2025-08-06
$8.48M
derived: sum of 3 quarters · filed 2026-03-04
$10.85M
derived: sum of 4 quarters · filed 2026-03-04
2024-03-31$2.80M
10-Q · filed 2025-05-08
$5.55M
derived: sum of 2 quarters · filed 2026-03-04
$7.91M
derived: sum of 3 quarters · filed 2026-03-04
$11.21M
derived: sum of 4 quarters · filed 2026-03-04
2023-12-31$2.75M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04
$5.11M
derived: sum of 2 quarters · filed 2026-03-04
$8.41M
derived: sum of 3 quarters · filed 2026-03-04
$10.53M
10-K · filed 2026-03-04
2023-09-30$2.36M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07
$5.67M
derived: sum of 2 quarters · filed 2024-11-07
$7.78M
10-Q · filed 2024-11-07
$9.48M
derived: sum of 4 quarters · filed 2025-03-05
2023-06-30$3.30M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06
$5.42M
10-Q · filed 2024-08-06
$7.12M
derived: sum of 3 quarters · filed 2025-03-05
$8.80M
derived: sum of 4 quarters · filed 2025-03-05
2023-03-31$2.11M
10-Q · filed 2024-05-07
$3.81M
derived: sum of 2 quarters · filed 2025-03-05
$5.50M
derived: sum of 3 quarters · filed 2025-03-05
$7.27M
derived: sum of 4 quarters · filed 2025-03-05
2022-12-31$1.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05
$3.38M
derived: sum of 2 quarters · filed 2025-03-05
$5.15M
derived: sum of 3 quarters · filed 2025-03-05
$6.68M
10-K · filed 2025-03-05
2022-09-30$1.68M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07
$3.45M
derived: sum of 2 quarters · filed 2023-11-07
$4.98M
10-Q · filed 2023-11-07
$6.65M
derived: sum of 4 quarters · filed 2024-03-08
2022-06-30$1.77M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01
$3.30M
10-Q · filed 2023-08-01
$4.97M
derived: sum of 3 quarters · filed 2024-03-08
$6.41M
derived: sum of 4 quarters · filed 2024-03-08
2022-03-31$1.53M
10-Q · filed 2023-05-02
$3.20M
derived: sum of 2 quarters · filed 2024-03-08
$4.64M
derived: sum of 3 quarters · filed 2024-03-08
$6.05M
derived: sum of 4 quarters · filed 2024-03-08
2021-12-31$1.67M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08
$3.11M
derived: sum of 2 quarters · filed 2024-03-08
$4.53M
derived: sum of 3 quarters · filed 2024-03-08
$5.84M
10-K · filed 2024-03-08
2021-09-30$1.44M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01
$2.85M
derived: sum of 2 quarters · filed 2022-11-01
$4.17M
10-Q · filed 2022-11-01
$5.65M
derived: sum of 4 quarters · filed 2023-03-01
2021-06-30$1.42M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04
$2.73M
10-Q · filed 2022-08-04
$4.21M
derived: sum of 3 quarters · filed 2023-03-01
$5.47M
derived: sum of 4 quarters · filed 2023-03-01
2021-03-31$1.32M
10-Q · filed 2022-05-05
$2.80M
derived: sum of 2 quarters · filed 2023-03-01
$4.06M
derived: sum of 3 quarters · filed 2023-03-01
$6.55M
derived: sum of 4 quarters · filed 2023-03-01
2020-12-31$1.48M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01
$2.74M
derived: sum of 2 quarters · filed 2023-03-01
$5.24M
derived: sum of 3 quarters · filed 2023-03-01
$6.20M
10-K · filed 2023-03-01
2020-09-30$1.26M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04
$3.75M
derived: sum of 2 quarters · filed 2021-11-04
$4.71M
10-Q · filed 2021-11-04
$5.42M
derived: sum of 4 quarters · filed 2022-03-03
2020-06-30$2.50M
10-Q · filed 2020-08-06
$3.45M
10-Q · filed 2021-08-05
$4.16M
derived: sum of 3 quarters · filed 2022-03-03
$4.89M
derived: sum of 4 quarters · filed 2022-03-03
2020-03-31$958.00K
10-Q · filed 2021-05-06
$1.67M
derived: sum of 2 quarters · filed 2022-03-03
$2.40M
derived: sum of 3 quarters · filed 2022-03-03
$3.09M
derived: sum of 4 quarters · filed 2022-03-03
2019-12-31$707.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03
$1.44M
derived: sum of 2 quarters · filed 2022-03-03
$2.13M
derived: sum of 3 quarters · filed 2022-03-03
$2.60M
10-K · filed 2022-03-03
2019-09-30$733.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05
$1.43M
derived: sum of 2 quarters · filed 2020-11-05
$1.90M
10-Q · filed 2020-11-05
$2.18M
derived: sum of 4 quarters · filed 2021-03-11
2019-06-30$692.00K
10-Q · filed 2020-08-06
$1.16M
10-Q · filed 2020-08-06
$1.45M
derived: sum of 3 quarters · filed 2021-03-11
$1.72M
derived: sum of 4 quarters · filed 2021-03-11
2019-03-31$471.00K
10-Q · filed 2020-05-06
$757.00K
derived: sum of 2 quarters · filed 2021-03-11
$1.02M
derived: sum of 3 quarters · filed 2021-03-11
$1.48M
derived: sum of 4 quarters · filed 2021-03-11
2018-12-31$286.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11
$554.00K
derived: sum of 2 quarters · filed 2021-03-11
$1.01M
derived: sum of 3 quarters · filed 2021-03-11
$3.19M
10-K · filed 2021-03-11
2018-09-30$268.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08
$722.00K
derived: sum of 2 quarters · filed 2019-11-08
$2.90M
10-Q · filed 2019-11-08
$5.30M
derived: sum of 4 quarters · filed 2020-03-05
2018-06-30$454.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13
$2.63M
10-Q · filed 2019-08-13
$5.03M
derived: sum of 3 quarters · filed 2020-03-05
$5.38M
derived: sum of 4 quarters · filed 2020-03-05
2018-03-31$2.18M
10-Q · filed 2019-05-09
$4.57M
derived: sum of 2 quarters · filed 2020-03-05
$4.93M
derived: sum of 3 quarters · filed 2020-03-05
$5.32M
derived: sum of 4 quarters · filed 2020-03-05
2017-12-31$2.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-05
$2.75M
derived: sum of 2 quarters · filed 2020-03-05
$3.14M
derived: sum of 3 quarters · filed 2020-03-05
$3.48M
10-K · filed 2020-03-05
2017-09-30$354.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31
$742.00K
derived: sum of 2 quarters · filed 2018-10-31
$1.08M
10-Q · filed 2018-10-31
$1.38M
derived: sum of 4 quarters · filed 2019-03-07
2017-06-30$388.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09
$727.00K
10-Q · filed 2018-08-09
$1.03M
derived: sum of 3 quarters · filed 2019-03-07
2017-03-31$339.00K
10-Q · filed 2018-05-15
$639.00K
derived: sum of 2 quarters · filed 2019-03-07
2016-12-31$300.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07
$1.25M
10-K · filed 2019-03-07
2016-09-30$951.00K
10-Q · filed 2017-11-13
2015-12-31$1.23M
10-K · filed 2018-03-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
SS Innovations International, Inc. (SSII)$0.589B-64.06
DELCATH SYSTEMS, INC. (DCTH)United States$0.558B820.33
ANGIODYNAMICS INC (ANGO)United States$0.632B-13.02
CERUS CORP (CERS)United States$0.525B-86.40
TACTILE SYSTEMS TECHNOLOGY INC (TCMD)United States$0.519B27.16
MIMEDX GROUP, INC. (MDXG)United States$0.687B89.92
NeuroPace Inc (NPCE)United States$0.480B-28.52
Sight Sciences, Inc. (SGHT)United States$0.478B-9.95
ClearPoint Neuro, Inc. (CLPT)United States$0.446B-15.74
CARLSMED, INC. (CARL)United States$0.405B